S. J. Cauchemez - Infectious Diseases

Author Information

Simon Cauchemez is associated with the Mathematical Modelling of Infectious Diseases Unit at the Institut Pasteur, located in Paris, France. His work primarily focuses on the use of mathematical models to understand and control infectious disease dynamics. He is affiliated with the UMR2000, CNRS, and is based in Paris. Simon Cauchemez has a significant contribution to the field, particularly in the context of recent global health challenges.

Research Contributions

Simon Cauchemez has made substantial contributions to the field of infectious disease modeling, with a focus on understanding epidemic dynamics and evaluating intervention strategies. In 2022, his research included studies on MERS-CoV vaccination strategies for healthcare workers, the transmission dynamics of COVID-19 in France, and the impact of vaccination on SARS-CoV-2 transmission in various settings. His work often involves the application of complex epidemiological models to inform public health decisions, including agent-based modeling and the study of antibody dynamics in relation to influenza.

Aliases

Simon Cauchemez is known by several aliases in academic publications, including S Cauchemez, S. Cauchemez, and S. J. Cauchemez. These variations are used interchangeably in his publications.

Publication and Citation Metrics

Metric	Value
Total Citation Count	23,254
H-index	65
Total Paper Count	287

Publications:

Prophylactic and reactive vaccination strategies for healthcare workers against MERS-CoV

DOI: 10.1101/2022.04.06.22273497

Year: 2022

Early chains of transmission of COVID-19 in France, January to March 2020

DOI: 10.2807/1560-7917.ES.2022.27.6.2001953

Year: 2022

Epidemic models: why and how to use them

DOI: 10.1016/j.accpm.2022.101048

Year: 2022

Epidemiology and control of SARS-CoV-2 epidemics in partially vaccinated populations: a modeling study applied to France

DOI: 10.1186/s12916-022-02235-1

Year: 2022

Publisher Correction: Monitoring key epidemiological parameters of SARS-CoV-2 transmission

DOI: 10.1038/s41591-021-01670-6

Year: 2022

Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19

DOI: 10.1038/s41467-022-29015-y

Year: 2022

Impact of BNT162b2 vaccination and isolation on SARS-CoV-2 transmission in Israeli households: an observational study

DOI: 10.1093/aje/kwac042

Year: 2022

Screening and vaccination against COVID-19 to minimise school closure: a modelling study

DOI: 10.1016/S1473-3099(22)00138-4

Year: 2022

Reconstructing antibody dynamics to estimate the risk of influenza virus infection

DOI: 10.1038/s41467-022-29310-8

Year: 2022

Impact of booster vaccination on the control of COVID-19 Delta wave in the context of waning immunity: application to France in the winter 2021/22

DOI: 10.2807/1560-7917.ES.2022.27.1.2101125

Year: 2022

How to Properly Use and Dispose of Masks?

How Can HFMD Be Prevented?

How Does Inherited Immunity Work?

What Role Does the CDC Play in Infectious Diseases?

How Do Immunodeficiency Disorders Affect the Body?

How is Cervical Cancer Linked to Infectious Diseases?

What is the Global Impact of Dengue Hemorrhagic Fever?

What is a PCR Test?

Are There Any Complications?

What are the Treatment Options for ARDS?

Partnered Content Networks

Relevant Topics